Decreased B Lymphocyte Activation
- Name
- Decreased B Lymphocyte Activation
- Accession Number
- DBCAT004412
- Description
Not Available
- Drugs
Drug Drug Description Belimumab A B-lymphocyte stimulator (BLyS)-specific inhibitor used to treat systemic lupus erythematosus and active lupus nephritis as an add-on therapy. - Drugs & Drug Targets
Drug Target Type Belimumab Tumor necrosis factor ligand superfamily member 13B target